Association of MMP8 gene variation with an increased risk of malignant melanoma

Melanoma Research

Volumn 21, Issue 5, 2011, Pages 464-468

  Dȩbniak, Tadeusz ^a   Jakubowska, Anna ^a   Serrano Fernández, Pablo ^a   Kurzawski, Grzegorz ^a   Cybulski, Cezary ^a   Chauhan, Saleena Rani ^b   Laxton, Ross C ^b   Maleszka, Romuald ^a   Lubinski, Jan ^a   Ye, Shu ^b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

breast cancer; malignant melanoma; MMP1; MMP8

Indexed keywords

INTERSTITIAL COLLAGENASE; NEUTROPHIL COLLAGENASE;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; RISK ASSESSMENT;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 8; MELANOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SKIN NEOPLASMS;

EID: 80052661945     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0b013e3283485fdd     Document Type: Article

References (26)

1. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumor invasion and metastasis. Eur J Cancer 2000; 36:1621-1630. (Pubitemid 30616366)
2. Barsky SH, Siegal GP, Jannotta F, Liotta LA. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Investig 1983; 49:140-147. (Pubitemid 13039938)
3. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284:67-68. (Pubitemid 10098769)
4. Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999; 13:781-792. (Pubitemid 29220691)
5. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2:161-174. (Pubitemid 37328786)
6. Cotignola J, Reva B, Mitra N, Ishill N, Chuai S, Patel A, et al. Matrix metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma. BMC Med Genet 2007; 8:10.
7. Elander N, Soderkvist P, Fransen K. Matrix metalloproteinase (MMP)-1,-2,-3 and-9 promoter polymorphisms in colorectal cancer. Anticancer Res 2006; 26:791-795. (Pubitemid 43206050)
8. Heist RS, Marshall AL, Liu G, Zhou W, Su L, Neuberg D, et al. Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer. Clin Cancer Res 2006; 12:5448-5453. (Pubitemid 44497260)
9. Kader AK, Liu J, Shao L, Dinney CP, Lin J, Wang Y, et al. Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness. Clin Cancer Res 2007; 13:2614-2620. (Pubitemid 46788027)
10. Lei H, Hemminki K, Altieri A, Johansson R, Enquist K, Hallmans G, et al. Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression. Breast Cancer Res Treat 2007; 103:61-69. (Pubitemid 46653260)
11. Miao X, Yu C, Tan W, Xiong P, Liang G, Lu W, et al. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 2003; 63:3987-3990. (Pubitemid 36917916)
12. Nan H, Niu T, Hunter DJ, Han J. Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 12:3551-3557.
13. Przybylowska K, Kluczna A, Zadrozny M, Krawczyk T, Kulig A, Rykala J, et al. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast Cancer Res Treat 2006; 95:65-72. (Pubitemid 43228082)
14. González-Arriaga P, López-Cima MF, Fernández-Somoano A, Pascual T, Marrón MG, Puente XS. Polymorphism +17 C/G in matrix metalloprotease MMP8 decreases lung cancer risk. BMC Cancer 2008; 8:378.
15. Goldstein AM, Tucker MA. Genetic epidemiology of familial melanoma. Dermatol Clin 1995; 13:605-612.
16. Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Bressac-de Paillerets B, et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002; 94:894-903. (Pubitemid 34778088)
17. Cybulski C, Górski B, Huzarski T, Masojć B, Mierzejewski M, Debniak T, et al. CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 2004; 75:1131-1135. (Pubitemid 39532081)
18. Goldstein AM, Fraser MC, Struewing JP, Hussussian CJ, Ranade K, Zametkin DP, et al. Increased risk of pancreatic cancer in melanoma-prone families with p16INK4 mutations. New Engl J Med 1995; 333:970-974.
19. Debniak T, Górski B, Huzarski T, Byrski T, Cybulski C, Mackiewicz A, et al. A common variant of CDKN2A (p16) predisposes to breast cancer. J Med Genet 2005; 42:763-765. (Pubitemid 41475251)
20. Debniak T, Scott RJ, Huzarski T, Byrski T, Masojć B, van de Wetering T, et al. XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat 2006; 98: 209-215. (Pubitemid 44050771)
21. Palavalli LH, Prickett TD, Wunderlich JR, Wei X, Burrell AS, Porter-Gill P, et al. Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma. Nat Genet 2009; 41:518-520.
22. Stadlmann S, Pollheimer J, Moser PL, Raggi A, Amberger A, Margreiter R, et al. Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer. Eur J Cancer 2003; 39: 2499-2505. (Pubitemid 37340163)
23. Decock J, Long JR, Laxton RC, Shu XO, Hodgkinson C, Hendrickx W, et al. Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis. Cancer Res 2007; 67:10214-10221. (Pubitemid 350070794)
24. Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, Corda E, et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 2009; 41:920-925.
25. The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers: the breast cancer linkage consortium. J Natl Cancer Inst 1999; 91:1310-1316.
26. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, et al. Melanocortin 1 receptor (MC1R) gene variants are associatedwith an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001; 117: 294-300. (Pubitemid 34205714)